Actual usage and clinical effectiveness of insulin preparations in patients with Type 1 diabetes mellitus in Japan: CoDiC-based analysis of clinical data obtained at multiple institutions (JDDM 3)

Diabetes Research and Clinical Practice
Azuma KanatsukaJapan Diabetes Clinical Data Management Study Group

Abstract

To clarify the actual usage of insulin preparations and their effectiveness on glycaemic control in patients with Type 1 diabetes mellitus in Japan, we analyzed clinical data collected via CoDiC, an electronic system for diabetes data collection and management, at 28 institutes. Of 18,470 diabetic patients registered with CoDiC in June, 2003, 12,279 patients were being treated with insulin preparations and/or oral hypoglycemic agents, with 861 of these patients having Type 1 diabetes mellitus and 11,418 patients having Type 2 diabetes. Three analytical surveys were carried out with the Type 1 diabetes patients. Study I: Cross-sectional survey on the treatment in 2002. Six hundred and thirteen patients received intensive conventional insulin treatment (ICT). The number of patients receiving rapid-acting insulin analogue (RA) was greater than that of patients receiving regular insulin (R). Serum CPR was lower in the patients with ICT than in the patients with conventional insulin treatment (CT). Study II: Survey on the changes in the actual usage and clinical effectiveness of insulin preparations, based on the data input in 2001 and 2002. The number of patients with ICT using RA insulin markedly increased. Study III: Analysis of ...Continue Reading

References

Mar 1, 1995·Diabetic Medicine : a Journal of the British Diabetic Association·M Berger, I Mühlhauser
Mar 14, 2003·Bone·S KobayashiK Takaoka

❮ Previous
Next ❯

Citations

Oct 2, 2009·Diabetes/metabolism Research and Reviews·Susan E NevilleRisa P Hayes
Jan 29, 2013·Journal of Diabetes Investigation·Yasuhiko IwamotoKohei Kaku
Nov 21, 2014·Journal of Diabetes Investigation·Azuma KanatsukaUNKNOWN Japan Diabetes Clinical Data Management Study Group
Jun 23, 2016·Journal of Diabetes Investigation·Azuma KanatsukaAtsuyoshi Yuhara
Oct 18, 2007·Current Opinion in Endocrinology, Diabetes, and Obesity

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Related Papers

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Satish GargMartin Pfohl
Diabetic Medicine : a Journal of the British Diabetic Association
Simon HellerA Lindholm
Expert Opinion on Pharmacotherapy
Domenico Cucinotta, Giuseppina T Russo
International Journal of Clinical Practice. Supplement
T Kunt
© 2022 Meta ULC. All rights reserved